Ceramide-β-D-glucuronide: Synthesis, digestion, and suppression of early markers of colon carcinogenesis

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5768-5772

  Schmelz, Eva M ^a   Bushnev, Anatoliy S ^b   Dillehay, Dirck L ^a   Sullards, M Cameron ^a   Liotta, Dennis C ^b   Merrill Jr , Alfred H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BETA GLUCURONIDASE; CERAMIDE; GLUCURONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESCHERICHIA COLI; FEMALE; GLUCURONIDATION; HYDROLYSIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTICARCINOGENIC AGENTS; BACTERIAL PROTEINS; CARCINOGENS; CERAMIDES; COLON; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; ESCHERICHIA COLI; FEMALE; GLUCOSYLCERAMIDES; GLUCURONIC ACIDS; GLUCURONIDASE; HYDROLYSIS; MICE; PRECANCEROUS CONDITIONS; WEIGHT GAIN;

EID: 0033571163     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Cancer Society. Cancer Facts and Figures. American Cancer Society Publ. No. 5008. Atlanta, GA: American Cancer Society, 1999.
2. Dillehay, D. L., Webb, S. K., Schmelz, E. M., and Merrill, A. H., Jr. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J. Nutr, 124: 615-620, 1994.
3. Schmelz, E. M., Dillehay, D. L., Webb, S. K., Reiter, A., Adams, J., and Merrill, A. H., Jr. Sphingomyelin consumption suppresses aberrant colonie crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res., 56: 4936-4941, 1996.
4. Schmelz, E. M., Bushnev, A. S., Dillehay, D. L., Liotta, D. C., and Merrill, A. H., Jr. Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbone. Nutr. Cancer, 28: 81-85, 1997.
5. Vesper, H., Schmelz, E. M., Dillehay, D. L., Lynch, D., and Merrill, A. H., Jr. Sphingolipids in food and the emerging importance of sphingolipids in nutrition. J. Nutr., 129: 1239-1250, 1999.
6. Schmelz, E. M., Crall, K. J., Larocque, R., Dillehay, D. L., and Merrill, A. H., Jr. Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr., 124: 702-712, 1994.
7. Nilsson, Å. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim. Biophys. Acta, 164: 575-584, 1968.
8. Nilsson, Å. Metabolism of cerebrosides in the intestinal tract of the rat. Biochim. Biophys. Acta, 187: 113-121, 1969.
9. Haeberlin, B., Rubas, W., Nolen, H. W., and Friend, D. R. In vitro evaluation of dexamethasone-β-D-glucuronide for colon-specific drug delivery. Pharmacol. Res., 10: 1553-1562, 1993.
10. Barua, A. B. Retinoyl β-glucuronide. a biologically active form of vitamin A. Nutr. Rev., 55: 259-267, 1997.
11. Nolen, N., Fedorak, R. N., and Freind, D. R. Budesonide-β-D-glucuronide: a potential prodrug for treatment of ulcerative colitis. J. Pharm. Sci., 84: 677-681, 1995.
12. Vlahov, J., and Snatzke, G. Über eine verbesserte Synthese von β-Glucosiduronsäurederivaten. Liebigs Ann. Chem., 570-574, 1983.
13. Koike, K., Mori, M., Ito, Y., Nakahara, Y., and Ogawa, T. Stereoselective total synthesis of wheat flour ceramide dihexoside. Agric. Biol. Chem., 54: 2931-2939, 1990.
14. Brown, R. T., Carter, N. E., Lumbard, K. W., and Scheinmann, F. Synthesis of a morphine-6-glucuronide hapten. N-(4-aminobutyl) normorphine-6-glucuronide, and related haptens. Tetrahedron Lett., 36: 8661-8664, 1995.
15. Schmidt, R. R., and Grundler, G. Einfache Synthese von β-D-glucopyranosyluronaten. Synthesis, 885-887, 1981.
16. Garner, P., and Park, J. M. The synthesis and configurational stability of differentially protected β-hydroxyl-α-amino aldehydes. J. Org. Chem., 52: 2361-2364, 1987.
17. Garner, P., Park, J. M., and Malecki, E. A stereodivergent synthesis of D-erythro sphingosine and D-threo sphingosine from L-serine. J. Org. Chem., 53: 4395-4398, 1988.
18. Garner, P., and Park, J. M. 1,I-Dimethylethyl (S)- or (R)-4-formyl-2,2-dimethyl-3-oxazolidinecarboxylate: a useful serinal derivative. Org. Synth., 70: 18-28, 1991.
19. Herold, P. Synthesis of D-erythro- and D-threo-sphingosine derivatives from L-serine. Helv. Chim. Acta, 71: 354-362, 1988.
20. Nimkar, S., Menaldino, D., Merrill, A. H., Jr., and Liotta, D. C. A stereoselective synthesis of sphingosine, a protein kinase C inhibitor. Tetrahedron. Lett., 29: 3037-3040, 1988.
21. Bushnev, A. S., and Liotta, D. C. Practical synthesis of N-palmitoylsphingomyelin and N-palmitoyldihydrosphingomyelin. In: A. H. Merrill, Jr. and Y. A. Hannun (eds.). Methods in Enzymology, Vol. 311, Chapter 45. San Diego, CA: Academic Press, 1999.
22. Schmidt, R. R., and Kläger, R. Short synthesis of cerebrosides. Angew. Chem. Int. Ed. Engl., 24: 65-66, 1985.
23. Koike, K., Sugimoto, M., Nakahara, Y., and Ogawa, T. Selective synthesis of cerebrosides: (2S,3R,4E)-1-O-β-D-galactopyranosyl-N-(1-hydroxytetracosanoyl-sphingenine. Glycoconjug. J., 2: 105-108, 1985.
24. Gassman, P. G., and Schenk, W. N. A general procedure for the base-promoted hydrolysis of hindered esters at ambient temperatures. J. Org. Chem., 42: 918-920, 1977.
25. Schmelz, E. M., Sullards, M. C., Dillehay, D. L., and Merrill, A. H., Jr. Inhibition of colonie cell proliferation and aberrant crypt foci formation by dairy glycosphingo-lipids in 1,2-dimethylhydrazine-treated CF1 mice. J. Nutr., in press, 1999.
26. Ramabadran, K., Bansinath, M., Turndorf, H., and Puig, M. M. Stereospecific inhibition of gastrointestinal transit by κ opioid agonists in mice. Eur. J. Pharmacol., 155: 329-331, 1988.
27. Bansinath, M., and Bhargava, H. N. Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice. Neuropharmacology, 27: 433-437, 1988.
28. Evans, R. C., Kamm, M. A., Hinton, J. N., and Lennard-Jones, J. E. The normal range and sample diagram for recording whole gut transit time. Int. J. Colorectal Dis., 7: 15-17, 1992.
29. Dbaibo, G. S., Pushkareva, M. Y., Jayadev, S., Schwarz, J. K., Horowitz, J. M., Obeid, L. M., and Hannun, Y. A. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. USA, 92: 1347-1351, 1995.
30. 1 in CV-1 cells. Food Chem. Toxicol., 25: 1-13, 1998.
31. Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M. Y., Obeid, L. M., and Hannun, Y. A. Role for ceramide in cell cycle arrest. J. Biol. Chem., 270: 2047-2052, 1995.
32. Ohta, H., Sweeney, E. A., Masamune, A., Yatomi, Y., Hakomori, S-I., and Igarashi, Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res., 55: 691-697, 1995.
33. Kim, M. Y., Linardic, C., Obeid, L. M., and Hannun, Y. A. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor a and γ-Interferon. J. Biol. Chem., 266: 484-489, 1991.
34. Marcu, K. B., Bossone, S. A., and Patel, A. J. Myc function and regulation. Annu. Rev. Biochem., 61: 809-860, 1992.
35. Hannun, Y. A., Loomis, C. R., Merrill, A. H., Jr., and Bell, R. M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem., 261: 12604-12609, 1986.
36. Stevens, V. L., Owens, N. E., Winton, E. F., Kinkade, J. M., and Merrill, A. H., Jr. Modulation of retinoic acid-induced differentiation of human leukemia (HL-60) cells by serum factors and sphinganine. Cancer Res., 50: 222-226, 1990.
37. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. Programmed cell death induced by ceramide. Science (Washington DC), 259: 1769-1771, 1993.
38. Sweeney, E. A., Sakakura, C., Shirahama, T., Masamune, A., Ohta, H., Hakomori, S. I., and Igarashi, Y. Sphingosine and its methylated derivative N,N-dimethyl sphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer, 66: 358-366, 1996.